Definium Therapeutics, Inc. Long-term Line of Credit, Noncurrent
Definium Therapeutics, Inc. (DFTX) had Long-term Line of Credit, Noncurrent of $36.47 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermLineOfCredit · last filed 2026-08-06
- 2026-06-30: Long-term Line of Credit, Noncurrent $36.47M.
- 2026-03-31: Long-term Line of Credit, Noncurrent $40.77M.
- 2025-12-31: Long-term Line of Credit, Noncurrent $40.58M.
- 2025-09-30: Long-term Line of Credit, Noncurrent $40.38M.
| Period end | Long-term Line of Credit, Noncurrent |
|---|---|
| 2026-06-30 | $36.47M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $40.77M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $40.58M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $40.38M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $41.19M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $22.04M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $21.85M 10-K · filed 2026-02-26 |
| 2024-09-30 | $24.31M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $24.25M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $14.19M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $14.13M 10-K · filed 2025-03-06 |
| 2023-09-30 | $14.07M 10-Q · filed 2023-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |